GU Cancers Symposium 2013 - Updated interim analysis (55% OS) of COU-AA-302, a randomized phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy - Slide Lecture
ORLANDO, FL, USA (UroToday.com) - Presented by Charles J. Ryan, MD, et al. at the 2013 Genitourinary Cancers Symposium - February 14 - 16, 2013 - Rosen Shingle Creek - Orlando, Florida USA
Free Daily and Weekly newsletters offered by content of interest
The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.